Aug 5 (Reuters) - Generic drug maker Actavis Plc’s quarterly revenue rose 34 percent due to strong growth in its North America business.
The company had a net profit of $48.7 million, or 28 cents per share, attributable to shareholders for the second quarter ended June 30.
A year earlier, it had a net loss of $564.8 million, or $4.27 per share.
Excluding items, Actavis earned $3.42 per share in the second quarter.
Revenue rose to $2.67 billion from $1.99 billion, a year earlier. (Reporting by Anjali Rao Koppala in Bangalore; Editing by Kirti Pandey)